Fresenius Medical Care AG (FMS)
20.88
+0.20
(+0.99%)
USD |
NYSE |
May 09, 15:27
Fresenius Medical Care Cash from Investing (TTM): -488.08M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -488.08M |
December 31, 2023 | -589.19M |
September 30, 2023 | -748.78M |
June 30, 2023 | -662.64M |
March 31, 2023 | -713.08M |
December 31, 2022 | -774.84M |
September 30, 2022 | -1.017B |
June 30, 2022 | -1.281B |
March 31, 2022 | -1.382B |
December 31, 2021 | -1.415B |
September 30, 2021 | -1.407B |
June 30, 2021 | -1.442B |
March 31, 2021 | -1.450B |
December 31, 2020 | -1.525B |
September 30, 2020 | -1.656B |
June 30, 2020 | -1.644B |
March 31, 2020 | -1.733B |
December 31, 2019 | -3.679B |
September 30, 2019 | -3.524B |
June 30, 2019 | -4.017B |
March 31, 2019 | -2.089B |
December 31, 2018 | -289.34M |
September 30, 2018 | 247.80M |
June 30, 2018 | 720.66M |
March 31, 2018 | -1.236B |
Date | Value |
---|---|
December 31, 2017 | -1.123B |
September 30, 2017 | -1.640B |
June 30, 2017 | -1.519B |
March 31, 2017 | -1.420B |
December 31, 2016 | -1.379B |
September 30, 2016 | -1.179B |
June 30, 2016 | -1.194B |
March 31, 2016 | -1.121B |
December 31, 2015 | -1.001B |
September 30, 2015 | -1.934B |
June 30, 2015 | -2.562B |
March 31, 2015 | -2.830B |
December 31, 2014 | -2.943B |
September 30, 2014 | -2.158B |
June 30, 2014 | -1.606B |
March 31, 2014 | -1.266B |
December 31, 2013 | -1.159B |
September 30, 2013 | -1.034B |
June 30, 2013 | -802.77M |
March 31, 2013 | -821.18M |
December 31, 2012 | -2.218B |
September 30, 2012 | -2.852B |
June 30, 2012 | -2.997B |
March 31, 2012 | -3.706B |
December 31, 2011 | -2.524B |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-4.017B
Minimum
Jun 2019
-488.08M
Maximum
Mar 2024
-1.557B
Average
-1.411B
Median
Cash from Investing (TTM) Benchmarks
Biodexa Pharmaceuticals Plc | -0.3289M |
NuCana PLC | 3.594M |
TC BioPharm (Holdings) PLC | -0.2614M |
DaVita Inc | -870.46M |
Bicycle Therapeutics PLC | -0.842M |